Condition: Colorectal Polyp · Sponsor: Instituto de Investigación Sanitaria Aragón
Dietary intervention with UNICLA-A2 milk products containing beta casein A2 protein, and higher levels of omega-3 fatty acids and selenium may contribute to maintain the intestinal integrity, reduce inflammatory processes, normalize the immune system, protect against oxidative damage and equilibrate the gut microbiota in high-risk colorectal cancer patients who have undergone polypectomy
This description comes directly from the study's public registry record.
Angel Lanas Arbeloa, MD, PhD · 0034 976 76 57 86 · alanas@unizar.es
Pilar Irun, PhD · mpirun.uit@gmail.com
Always discuss trial participation with your own doctor first.
| Angel Lanas Arbeloa | Zaragoza, Zaragoza, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04824053